A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications — including Ozempic, Wegovy and Mounjaro ...

Five scientists who pioneered GLP-1-based drugs Ozempic and Wegovy receive $3 million Breakthrough Prize for life-changing ...

Advances recognized by science’s most lucrative awards include Large Hadron Collider experiments and groundbreaking ...

Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.

Novo Nordisk today presented the full results from STRIDE, a phase 3b peripheral artery disease (PAD) outcomes trial investigating the effects of once-weekly injectable Ozempic® (semaglutide 1.0 mg) ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity in recent years due to their effectiveness in diabetes control and weight loss. Research has revealed additional ...

Ozempic is the newest craze to take over Hollywood. While stars like Kyle Richards have denied using the Type II diabetes medication — which is injected once a week into the stomach, thigh or ...

Saxenda (liraglutide) and Ozempic (semaglutide) are brand-name solutions for subcutaneous injection. Saxenda is approved for weight management. Doctors may prescribe Ozempic off-label for this ...

1:54 Ozempic: How a Canadian scientist and a venomous ... worth US$3 million with four colleagues from the United States and Denmark who were also involved in GLP1’s journey from the lab to ...